CN116209659A - 方法 - Google Patents
方法 Download PDFInfo
- Publication number
- CN116209659A CN116209659A CN202180052436.3A CN202180052436A CN116209659A CN 116209659 A CN116209659 A CN 116209659A CN 202180052436 A CN202180052436 A CN 202180052436A CN 116209659 A CN116209659 A CN 116209659A
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- reaction
- alkyl
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Seasonings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202511947370.0A CN121717789A (zh) | 2020-08-26 | 2021-08-24 | 由2-哌啶酸原位形成清凉剂的方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013383.1 | 2020-08-26 | ||
| GBGB2013383.1A GB202013383D0 (en) | 2020-08-26 | 2020-08-26 | Process |
| PCT/EP2021/073378 WO2022043320A1 (en) | 2020-08-26 | 2021-08-24 | Process |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202511947370.0A Division CN121717789A (zh) | 2020-08-26 | 2021-08-24 | 由2-哌啶酸原位形成清凉剂的方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116209659A true CN116209659A (zh) | 2023-06-02 |
Family
ID=72660759
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180052436.3A Pending CN116209659A (zh) | 2020-08-26 | 2021-08-24 | 方法 |
| CN202511947370.0A Pending CN121717789A (zh) | 2020-08-26 | 2021-08-24 | 由2-哌啶酸原位形成清凉剂的方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202511947370.0A Pending CN121717789A (zh) | 2020-08-26 | 2021-08-24 | 由2-哌啶酸原位形成清凉剂的方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230312506A1 (https=) |
| EP (1) | EP4204407B1 (https=) |
| JP (1) | JP7818578B2 (https=) |
| KR (1) | KR20230058096A (https=) |
| CN (2) | CN116209659A (https=) |
| BR (1) | BR112023002055A2 (https=) |
| CO (1) | CO2023003013A2 (https=) |
| ES (1) | ES2985349T3 (https=) |
| GB (1) | GB202013383D0 (https=) |
| IL (1) | IL300613A (https=) |
| MX (1) | MX2023002234A (https=) |
| PL (1) | PL4204407T3 (https=) |
| WO (1) | WO2022043320A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202105661D0 (en) * | 2021-04-21 | 2021-06-02 | Givaudan Sa | Organic compounds |
| WO2022207944A2 (en) | 2022-07-11 | 2022-10-06 | Symrise Ag | Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013163270A1 (en) * | 2012-04-25 | 2013-10-31 | Theravance, Inc. | Hepatitis c virus inhibitors |
| WO2015047973A1 (en) * | 2013-09-27 | 2015-04-02 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| WO2015054087A1 (en) * | 2013-10-07 | 2015-04-16 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| CN108129476A (zh) * | 2017-11-27 | 2018-06-08 | 华中农业大学 | 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA987383B (en) * | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
| WO2006091731A2 (en) * | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
| JP2009535327A (ja) * | 2006-04-25 | 2009-10-01 | ディシュマン・ファーマシューティカルズ・アンド・ケミカルズ・リミテッド | ロピバカイン塩酸塩無水物およびその調製 |
| TWI610916B (zh) * | 2012-08-03 | 2018-01-11 | 廣東東陽光藥業有限公司 | 作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用 |
| EP4045491A1 (en) * | 2019-10-17 | 2022-08-24 | Givaudan SA | Substituted azacyles as trmp8 modulators |
-
2020
- 2020-08-26 GB GBGB2013383.1A patent/GB202013383D0/en not_active Ceased
-
2021
- 2021-08-24 WO PCT/EP2021/073378 patent/WO2022043320A1/en not_active Ceased
- 2021-08-24 PL PL21769101.3T patent/PL4204407T3/pl unknown
- 2021-08-24 US US18/021,620 patent/US20230312506A1/en active Pending
- 2021-08-24 ES ES21769101T patent/ES2985349T3/es active Active
- 2021-08-24 EP EP21769101.3A patent/EP4204407B1/en active Active
- 2021-08-24 JP JP2023513348A patent/JP7818578B2/ja active Active
- 2021-08-24 IL IL300613A patent/IL300613A/en unknown
- 2021-08-24 KR KR1020237009953A patent/KR20230058096A/ko active Pending
- 2021-08-24 BR BR112023002055A patent/BR112023002055A2/pt unknown
- 2021-08-24 MX MX2023002234A patent/MX2023002234A/es unknown
- 2021-08-24 CN CN202180052436.3A patent/CN116209659A/zh active Pending
- 2021-08-24 CN CN202511947370.0A patent/CN121717789A/zh active Pending
-
2023
- 2023-03-13 CO CONC2023/0003013A patent/CO2023003013A2/es unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013163270A1 (en) * | 2012-04-25 | 2013-10-31 | Theravance, Inc. | Hepatitis c virus inhibitors |
| WO2015047973A1 (en) * | 2013-09-27 | 2015-04-02 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| WO2015054087A1 (en) * | 2013-10-07 | 2015-04-16 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| CN108129476A (zh) * | 2017-11-27 | 2018-06-08 | 华中农业大学 | 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途 |
Non-Patent Citations (1)
| Title |
|---|
| CHANDRABALAN, ARUNDHASA等: "N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 170, 4 March 2019 (2019-03-04), pages 141 - 156 * |
Also Published As
| Publication number | Publication date |
|---|---|
| IL300613A (en) | 2023-04-01 |
| JP2023538761A (ja) | 2023-09-11 |
| US20230312506A1 (en) | 2023-10-05 |
| WO2022043320A1 (en) | 2022-03-03 |
| ES2985349T3 (es) | 2024-11-05 |
| BR112023002055A2 (pt) | 2023-03-07 |
| KR20230058096A (ko) | 2023-05-02 |
| JP7818578B2 (ja) | 2026-02-20 |
| CO2023003013A2 (es) | 2023-04-17 |
| EP4204407B1 (en) | 2024-06-19 |
| EP4204407A1 (en) | 2023-07-05 |
| GB202013383D0 (en) | 2020-10-07 |
| PL4204407T3 (pl) | 2024-11-04 |
| CN121717789A (zh) | 2026-03-24 |
| MX2023002234A (es) | 2023-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101982952B1 (ko) | 피라졸 유도체의 제조 방법 | |
| CN116209659A (zh) | 方法 | |
| JP4376061B2 (ja) | アルケノンの製造 | |
| JP2024167399A (ja) | (5s)-4-[5-(3,5-ジクロロフェニル)-5-(トリフルオロメチル)-4h-イソオキサゾール-3-イル]-2-メチル-安息香酸の製造方法 | |
| TWI270548B (en) | Improved method for making nevirapine | |
| FR2650591A1 (fr) | Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| RU2839933C1 (ru) | Способ | |
| EP1268469A1 (fr) | N-(heterocyclyl)benzene-ou pyridine sulfonamides comme agents antithrombotiques et anticoagulants | |
| JP3407082B2 (ja) | アミノメチルピリジン誘導体の製造方法及びその中間体 | |
| JP2017530998A (ja) | 1−(3,5−ジクロロフェニル)−2,2,2−トリフルオロ−エタノン及びその誘導体の製造方法 | |
| JP3771334B2 (ja) | 2−メチル−3−(3,4−メチレンジオキシフェニル)アクリルアルデヒドの製法 | |
| Portella et al. | Perfluoroketene dithioacetals and perfluorodithiocarboxylic acid derivatives: Versatile tools for organofluorine synthesis | |
| JP2835785B2 (ja) | 光学活性2−(1−ヒドロキシアルキル)ベンズアルデヒド類の製法 | |
| JP4541143B2 (ja) | キノリン誘導体の製造方法 | |
| JP4509327B2 (ja) | N,n−ジ置換−4−アミノクロトン酸エステルの製造方法 | |
| JP2005528369A (ja) | 2−(7−クロロ−1,8−ナフチリジン−2−イル)−3−(5−メチル−2−オキソ−ヘキシル)−1−イソインドリノンの調製法 | |
| KR100343551B1 (ko) | 4-알콕시카르보닐-5-클로로피라졸 유도체의 제조방법 | |
| JP3777407B2 (ja) | カルボン酸誘導体の製造法 | |
| JP6764158B2 (ja) | カルボニル化合物の製造方法 | |
| LU82342A1 (fr) | Procede de preparation de 2-aminopyrazines substituees | |
| WO2002051789A1 (en) | Processes for preparing 2-fluoro-3-oxoalkylcarboxylic acid esters | |
| LU82341A1 (fr) | Hydroxyimino-aminoacetonitriles et leur preparation | |
| JPS6232181B2 (https=) | ||
| JPH04300847A (ja) | 4−オキソヘプタンジアール誘導体およびその製造方法 | |
| JP2006124283A (ja) | トリフルオロメチル基含有エナミンおよびその誘導体の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |